Liberate Bio Integrates Quantum-Si’s Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development

BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based biotech unleashing the potential of genetic medicines with novel delivery vehicles, has integrated the Platinum® Next-Generation Protein Sequencer™ (“NGPS”) into their platform for developing novel gene therapies with improved targeting capabilities. Liberate [...]

ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement

Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications  Dublin, Ireland, and Cheshire, UK: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Medicines Discovery Catapult (‘MDC’), an independent, not-for-profit drug discovery innovation centre, have signed a non-exclusive commercial-use CRISPR license agreement. The partnership combines ERS’s CRISPR/Cas9 patent [...]

LumaCyte Unveils Predictive CAR T Donor Analytics to Revolutionize Cell Therapy Manufacturing

CHARLOTTESVILLE, Va. -- LumaCyte, a leader in advanced cellular analysis and precision bioanalytics, proudly announces the launch of its groundbreaking cell therapy application for predictive CAR T donor analytics. Leveraging its novel Laser Force Cytology™ (LFC™) technology and Radiance® instrument, LumaCyte uncovers deep data insights into highly variable and complex patient and donor cellular starting [...]

NIH Awards Nirrin Technologies $2M SBIR Grant to Expand Development of HPTLS Technology Platform for Biomanufacturing

Grant will facilitate HPTLS platform development for additional biomanufacturing areas that face critical challenges, including upstream bioprocessing and in-line/in-situ applications Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, has been awarded a $2 million Small Business Innovation Research (SBIR) Direct Phase II Grant from the National Institutes of Health (NIH). This [...]

Takara Bio Launches Large-Scale, Flexible qPCR System to Advance Broad Surveillance of Antimicrobial Resistance

SAN JOSE, Calif. -- Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND™ Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for monitoring antimicrobial resistance (AMR), supporting efforts to ensure environmental safety and sustainability. The flexible system covers a variety of configurations, [...]

JEOL: New CROSS SECTION POLISHER™ IB-19540CP / IB-19550CCP Released

CROSS SECTION POLISHER™(CP)is widely utilized in the fields of electronic parts, ceramics, life science, metal, battery, and polymer. The mechanical high-quality uniform cross section can be easily prepared for complex materials and fragile specimens. With a sales record of over 2,000 units since its launch in 2003, the CP has been an essential tool for [...]

Carterra unveils its most sensitive biosensor platform; Carterra Ultra™ ushers in a new frontier in fragment and small molecule drug discovery

The new instrument enables high-throughput small and large molecule characterization in traditional and AI-driven workflows   Salt Lake City, Utah – Carterra Inc., the world leader in innovative technologies enabling high-throughput biology, today has launched Carterra Ultra™—the latest addition to its LSA® and LSAXT label-free high-throughput surface plasmon resonance (HT-SPR) instruments. The Ultra platform enables small molecule applications [...]

Royal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education

Royal Society Hosts BioAro's UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education NEW YORK -- BioAro successfully launched its presence in the UK at the Royal Society on August 29th, 2024. BioAro's UK launch marks a significant step in the company's mission to revolutionize precision medicine. Leveraging advanced AI-driven genomic analysis, [...]

BillionToOne Adopting Semaphore Solutions’ Labbit LIMS in its Precision Oncology Diagnostics Laboratories

VICTORIA, BC - Semaphore Solutions, a leader in laboratory informatics solutions, is pleased to announce the expansion of its partnership with next-generation molecular diagnostics company, BillionToOne. BillionToOne is implementing Semaphore’s Laboratory Information Management System (LIMS), Labbit, in their oncology laboratories in preparation for significant increases in sample throughput. BillionToOne’s unique technology, Quantitative Counting Templates™, QCTs™, enables counting DNA molecules [...]

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDM™ Platform at Morgan Stanley Healthcare Conference 2024

Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today launched the new generation of the SOPHiA DDM™ Platform. The new-gen SOPHiA DDM™ Platform offers a new architecture designed to more efficiently compute large amounts of data at-scale, while elevating customer experience with [...]

Access IBO on Knowledge Center